Global Ivosidenib Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Ivosidenib market size was valued at US$ 171.5 million in 2023. With growing demand in downstream market, the Ivosidenib is forecast to a readjusted size of US$ 241 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Ivosidenib market. Ivosidenib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ivosidenib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ivosidenib market.
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Key Features:
The report on Ivosidenib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ivosidenib market. It may include historical data, market segmentation by Type (e.g., 60 Tablets, 30 Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ivosidenib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ivosidenib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ivosidenib industry. This include advancements in Ivosidenib technology, Ivosidenib new entrants, Ivosidenib new investment, and other innovations that are shaping the future of Ivosidenib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ivosidenib market. It includes factors influencing customer ' purchasing decisions, preferences for Ivosidenib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ivosidenib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ivosidenib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ivosidenib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ivosidenib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ivosidenib market.
Market Segmentation:
Ivosidenib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Ivosidenib market?
What factors are driving Ivosidenib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ivosidenib market opportunities vary by end market size?
How does Ivosidenib break out type, application?
According to our LPI (LP Information) latest study, the global Ivosidenib market size was valued at US$ 171.5 million in 2023. With growing demand in downstream market, the Ivosidenib is forecast to a readjusted size of US$ 241 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Ivosidenib market. Ivosidenib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ivosidenib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ivosidenib market.
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Key Features:
The report on Ivosidenib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ivosidenib market. It may include historical data, market segmentation by Type (e.g., 60 Tablets, 30 Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ivosidenib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ivosidenib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ivosidenib industry. This include advancements in Ivosidenib technology, Ivosidenib new entrants, Ivosidenib new investment, and other innovations that are shaping the future of Ivosidenib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ivosidenib market. It includes factors influencing customer ' purchasing decisions, preferences for Ivosidenib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ivosidenib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ivosidenib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ivosidenib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ivosidenib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ivosidenib market.
Market Segmentation:
Ivosidenib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 60 Tablets
- 30 Tablets
- Hospital
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Servier Pharmaceuticals
What is the 10-year outlook for the global Ivosidenib market?
What factors are driving Ivosidenib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ivosidenib market opportunities vary by end market size?
How does Ivosidenib break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ivosidenib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ivosidenib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ivosidenib by Country/Region, 2019, 2023 & 2030
2.2 Ivosidenib Segment by Type
2.2.1 60 Tablets
2.2.2 30 Tablets
2.3 Ivosidenib Sales by Type
2.3.1 Global Ivosidenib Sales Market Share by Type (2019-2024)
2.3.2 Global Ivosidenib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ivosidenib Sale Price by Type (2019-2024)
2.4 Ivosidenib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Ivosidenib Sales by Application
2.5.1 Global Ivosidenib Sale Market Share by Application (2019-2024)
2.5.2 Global Ivosidenib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ivosidenib Sale Price by Application (2019-2024)
3 GLOBAL IVOSIDENIB BY COMPANY
3.1 Global Ivosidenib Breakdown Data by Company
3.1.1 Global Ivosidenib Annual Sales by Company (2019-2024)
3.1.2 Global Ivosidenib Sales Market Share by Company (2019-2024)
3.2 Global Ivosidenib Annual Revenue by Company (2019-2024)
3.2.1 Global Ivosidenib Revenue by Company (2019-2024)
3.2.2 Global Ivosidenib Revenue Market Share by Company (2019-2024)
3.3 Global Ivosidenib Sale Price by Company
3.4 Key Manufacturers Ivosidenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ivosidenib Product Location Distribution
3.4.2 Players Ivosidenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IVOSIDENIB BY GEOGRAPHIC REGION
4.1 World Historic Ivosidenib Market Size by Geographic Region (2019-2024)
4.1.1 Global Ivosidenib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ivosidenib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ivosidenib Market Size by Country/Region (2019-2024)
4.2.1 Global Ivosidenib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ivosidenib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ivosidenib Sales Growth
4.4 APAC Ivosidenib Sales Growth
4.5 Europe Ivosidenib Sales Growth
4.6 Middle East & Africa Ivosidenib Sales Growth
5 AMERICAS
5.1 Americas Ivosidenib Sales by Country
5.1.1 Americas Ivosidenib Sales by Country (2019-2024)
5.1.2 Americas Ivosidenib Revenue by Country (2019-2024)
5.2 Americas Ivosidenib Sales by Type
5.3 Americas Ivosidenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ivosidenib Sales by Region
6.1.1 APAC Ivosidenib Sales by Region (2019-2024)
6.1.2 APAC Ivosidenib Revenue by Region (2019-2024)
6.2 APAC Ivosidenib Sales by Type
6.3 APAC Ivosidenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ivosidenib by Country
7.1.1 Europe Ivosidenib Sales by Country (2019-2024)
7.1.2 Europe Ivosidenib Revenue by Country (2019-2024)
7.2 Europe Ivosidenib Sales by Type
7.3 Europe Ivosidenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ivosidenib by Country
8.1.1 Middle East & Africa Ivosidenib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ivosidenib Revenue by Country (2019-2024)
8.2 Middle East & Africa Ivosidenib Sales by Type
8.3 Middle East & Africa Ivosidenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ivosidenib
10.3 Manufacturing Process Analysis of Ivosidenib
10.4 Industry Chain Structure of Ivosidenib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ivosidenib Distributors
11.3 Ivosidenib Customer
12 WORLD FORECAST REVIEW FOR IVOSIDENIB BY GEOGRAPHIC REGION
12.1 Global Ivosidenib Market Size Forecast by Region
12.1.1 Global Ivosidenib Forecast by Region (2025-2030)
12.1.2 Global Ivosidenib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ivosidenib Forecast by Type
12.7 Global Ivosidenib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Servier Pharmaceuticals
13.1.1 Servier Pharmaceuticals Company Information
13.1.2 Servier Pharmaceuticals Ivosidenib Product Portfolios and Specifications
13.1.3 Servier Pharmaceuticals Ivosidenib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Servier Pharmaceuticals Main Business Overview
13.1.5 Servier Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ivosidenib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ivosidenib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ivosidenib by Country/Region, 2019, 2023 & 2030
2.2 Ivosidenib Segment by Type
2.2.1 60 Tablets
2.2.2 30 Tablets
2.3 Ivosidenib Sales by Type
2.3.1 Global Ivosidenib Sales Market Share by Type (2019-2024)
2.3.2 Global Ivosidenib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ivosidenib Sale Price by Type (2019-2024)
2.4 Ivosidenib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Ivosidenib Sales by Application
2.5.1 Global Ivosidenib Sale Market Share by Application (2019-2024)
2.5.2 Global Ivosidenib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ivosidenib Sale Price by Application (2019-2024)
3 GLOBAL IVOSIDENIB BY COMPANY
3.1 Global Ivosidenib Breakdown Data by Company
3.1.1 Global Ivosidenib Annual Sales by Company (2019-2024)
3.1.2 Global Ivosidenib Sales Market Share by Company (2019-2024)
3.2 Global Ivosidenib Annual Revenue by Company (2019-2024)
3.2.1 Global Ivosidenib Revenue by Company (2019-2024)
3.2.2 Global Ivosidenib Revenue Market Share by Company (2019-2024)
3.3 Global Ivosidenib Sale Price by Company
3.4 Key Manufacturers Ivosidenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ivosidenib Product Location Distribution
3.4.2 Players Ivosidenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IVOSIDENIB BY GEOGRAPHIC REGION
4.1 World Historic Ivosidenib Market Size by Geographic Region (2019-2024)
4.1.1 Global Ivosidenib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ivosidenib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ivosidenib Market Size by Country/Region (2019-2024)
4.2.1 Global Ivosidenib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ivosidenib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ivosidenib Sales Growth
4.4 APAC Ivosidenib Sales Growth
4.5 Europe Ivosidenib Sales Growth
4.6 Middle East & Africa Ivosidenib Sales Growth
5 AMERICAS
5.1 Americas Ivosidenib Sales by Country
5.1.1 Americas Ivosidenib Sales by Country (2019-2024)
5.1.2 Americas Ivosidenib Revenue by Country (2019-2024)
5.2 Americas Ivosidenib Sales by Type
5.3 Americas Ivosidenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ivosidenib Sales by Region
6.1.1 APAC Ivosidenib Sales by Region (2019-2024)
6.1.2 APAC Ivosidenib Revenue by Region (2019-2024)
6.2 APAC Ivosidenib Sales by Type
6.3 APAC Ivosidenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ivosidenib by Country
7.1.1 Europe Ivosidenib Sales by Country (2019-2024)
7.1.2 Europe Ivosidenib Revenue by Country (2019-2024)
7.2 Europe Ivosidenib Sales by Type
7.3 Europe Ivosidenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ivosidenib by Country
8.1.1 Middle East & Africa Ivosidenib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ivosidenib Revenue by Country (2019-2024)
8.2 Middle East & Africa Ivosidenib Sales by Type
8.3 Middle East & Africa Ivosidenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ivosidenib
10.3 Manufacturing Process Analysis of Ivosidenib
10.4 Industry Chain Structure of Ivosidenib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ivosidenib Distributors
11.3 Ivosidenib Customer
12 WORLD FORECAST REVIEW FOR IVOSIDENIB BY GEOGRAPHIC REGION
12.1 Global Ivosidenib Market Size Forecast by Region
12.1.1 Global Ivosidenib Forecast by Region (2025-2030)
12.1.2 Global Ivosidenib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ivosidenib Forecast by Type
12.7 Global Ivosidenib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Servier Pharmaceuticals
13.1.1 Servier Pharmaceuticals Company Information
13.1.2 Servier Pharmaceuticals Ivosidenib Product Portfolios and Specifications
13.1.3 Servier Pharmaceuticals Ivosidenib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Servier Pharmaceuticals Main Business Overview
13.1.5 Servier Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ivosidenib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ivosidenib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 60 Tablets
Table 4. Major Players of 30 Tablets
Table 5. Global Ivosidenib Sales by Type (2019-2024) & (Units)
Table 6. Global Ivosidenib Sales Market Share by Type (2019-2024)
Table 7. Global Ivosidenib Revenue by Type (2019-2024) & ($ million)
Table 8. Global Ivosidenib Revenue Market Share by Type (2019-2024)
Table 9. Global Ivosidenib Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Ivosidenib Sales by Application (2019-2024) & (Units)
Table 11. Global Ivosidenib Sales Market Share by Application (2019-2024)
Table 12. Global Ivosidenib Revenue by Application (2019-2024)
Table 13. Global Ivosidenib Revenue Market Share by Application (2019-2024)
Table 14. Global Ivosidenib Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Ivosidenib Sales by Company (2019-2024) & (Units)
Table 16. Global Ivosidenib Sales Market Share by Company (2019-2024)
Table 17. Global Ivosidenib Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Ivosidenib Revenue Market Share by Company (2019-2024)
Table 19. Global Ivosidenib Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Ivosidenib Producing Area Distribution and Sales Area
Table 21. Players Ivosidenib Products Offered
Table 22. Ivosidenib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ivosidenib Sales by Geographic Region (2019-2024) & (Units)
Table 26. Global Ivosidenib Sales Market Share Geographic Region (2019-2024)
Table 27. Global Ivosidenib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Ivosidenib Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Ivosidenib Sales by Country/Region (2019-2024) & (Units)
Table 30. Global Ivosidenib Sales Market Share by Country/Region (2019-2024)
Table 31. Global Ivosidenib Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Ivosidenib Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Ivosidenib Sales by Country (2019-2024) & (Units)
Table 34. Americas Ivosidenib Sales Market Share by Country (2019-2024)
Table 35. Americas Ivosidenib Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Ivosidenib Revenue Market Share by Country (2019-2024)
Table 37. Americas Ivosidenib Sales by Type (2019-2024) & (Units)
Table 38. Americas Ivosidenib Sales by Application (2019-2024) & (Units)
Table 39. APAC Ivosidenib Sales by Region (2019-2024) & (Units)
Table 40. APAC Ivosidenib Sales Market Share by Region (2019-2024)
Table 41. APAC Ivosidenib Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Ivosidenib Revenue Market Share by Region (2019-2024)
Table 43. APAC Ivosidenib Sales by Type (2019-2024) & (Units)
Table 44. APAC Ivosidenib Sales by Application (2019-2024) & (Units)
Table 45. Europe Ivosidenib Sales by Country (2019-2024) & (Units)
Table 46. Europe Ivosidenib Sales Market Share by Country (2019-2024)
Table 47. Europe Ivosidenib Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Ivosidenib Revenue Market Share by Country (2019-2024)
Table 49. Europe Ivosidenib Sales by Type (2019-2024) & (Units)
Table 50. Europe Ivosidenib Sales by Application (2019-2024) & (Units)
Table 51. Middle East & Africa Ivosidenib Sales by Country (2019-2024) & (Units)
Table 52. Middle East & Africa Ivosidenib Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Ivosidenib Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Ivosidenib Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Ivosidenib Sales by Type (2019-2024) & (Units)
Table 56. Middle East & Africa Ivosidenib Sales by Application (2019-2024) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Ivosidenib
Table 58. Key Market Challenges & Risks of Ivosidenib
Table 59. Key Industry Trends of Ivosidenib
Table 60. Ivosidenib Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Ivosidenib Distributors List
Table 63. Ivosidenib Customer List
Table 64. Global Ivosidenib Sales Forecast by Region (2025-2030) & (Units)
Table 65. Global Ivosidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Ivosidenib Sales Forecast by Country (2025-2030) & (Units)
Table 67. Americas Ivosidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Ivosidenib Sales Forecast by Region (2025-2030) & (Units)
Table 69. APAC Ivosidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Ivosidenib Sales Forecast by Country (2025-2030) & (Units)
Table 71. Europe Ivosidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Ivosidenib Sales Forecast by Country (2025-2030) & (Units)
Table 73. Middle East & Africa Ivosidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Ivosidenib Sales Forecast by Type (2025-2030) & (Units)
Table 75. Global Ivosidenib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Ivosidenib Sales Forecast by Application (2025-2030) & (Units)
Table 77. Global Ivosidenib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Servier Pharmaceuticals Basic Information, Ivosidenib Manufacturing Base, Sales Area and Its Competitors
Table 79. Servier Pharmaceuticals Ivosidenib Product Portfolios and Specifications
Table 80. Servier Pharmaceuticals Ivosidenib Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Servier Pharmaceuticals Main Business
Table 82. Servier Pharmaceuticals Latest Developments
Table 1. Ivosidenib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ivosidenib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 60 Tablets
Table 4. Major Players of 30 Tablets
Table 5. Global Ivosidenib Sales by Type (2019-2024) & (Units)
Table 6. Global Ivosidenib Sales Market Share by Type (2019-2024)
Table 7. Global Ivosidenib Revenue by Type (2019-2024) & ($ million)
Table 8. Global Ivosidenib Revenue Market Share by Type (2019-2024)
Table 9. Global Ivosidenib Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Ivosidenib Sales by Application (2019-2024) & (Units)
Table 11. Global Ivosidenib Sales Market Share by Application (2019-2024)
Table 12. Global Ivosidenib Revenue by Application (2019-2024)
Table 13. Global Ivosidenib Revenue Market Share by Application (2019-2024)
Table 14. Global Ivosidenib Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Ivosidenib Sales by Company (2019-2024) & (Units)
Table 16. Global Ivosidenib Sales Market Share by Company (2019-2024)
Table 17. Global Ivosidenib Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Ivosidenib Revenue Market Share by Company (2019-2024)
Table 19. Global Ivosidenib Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Ivosidenib Producing Area Distribution and Sales Area
Table 21. Players Ivosidenib Products Offered
Table 22. Ivosidenib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ivosidenib Sales by Geographic Region (2019-2024) & (Units)
Table 26. Global Ivosidenib Sales Market Share Geographic Region (2019-2024)
Table 27. Global Ivosidenib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Ivosidenib Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Ivosidenib Sales by Country/Region (2019-2024) & (Units)
Table 30. Global Ivosidenib Sales Market Share by Country/Region (2019-2024)
Table 31. Global Ivosidenib Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Ivosidenib Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Ivosidenib Sales by Country (2019-2024) & (Units)
Table 34. Americas Ivosidenib Sales Market Share by Country (2019-2024)
Table 35. Americas Ivosidenib Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Ivosidenib Revenue Market Share by Country (2019-2024)
Table 37. Americas Ivosidenib Sales by Type (2019-2024) & (Units)
Table 38. Americas Ivosidenib Sales by Application (2019-2024) & (Units)
Table 39. APAC Ivosidenib Sales by Region (2019-2024) & (Units)
Table 40. APAC Ivosidenib Sales Market Share by Region (2019-2024)
Table 41. APAC Ivosidenib Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Ivosidenib Revenue Market Share by Region (2019-2024)
Table 43. APAC Ivosidenib Sales by Type (2019-2024) & (Units)
Table 44. APAC Ivosidenib Sales by Application (2019-2024) & (Units)
Table 45. Europe Ivosidenib Sales by Country (2019-2024) & (Units)
Table 46. Europe Ivosidenib Sales Market Share by Country (2019-2024)
Table 47. Europe Ivosidenib Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Ivosidenib Revenue Market Share by Country (2019-2024)
Table 49. Europe Ivosidenib Sales by Type (2019-2024) & (Units)
Table 50. Europe Ivosidenib Sales by Application (2019-2024) & (Units)
Table 51. Middle East & Africa Ivosidenib Sales by Country (2019-2024) & (Units)
Table 52. Middle East & Africa Ivosidenib Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Ivosidenib Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Ivosidenib Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Ivosidenib Sales by Type (2019-2024) & (Units)
Table 56. Middle East & Africa Ivosidenib Sales by Application (2019-2024) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Ivosidenib
Table 58. Key Market Challenges & Risks of Ivosidenib
Table 59. Key Industry Trends of Ivosidenib
Table 60. Ivosidenib Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Ivosidenib Distributors List
Table 63. Ivosidenib Customer List
Table 64. Global Ivosidenib Sales Forecast by Region (2025-2030) & (Units)
Table 65. Global Ivosidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Ivosidenib Sales Forecast by Country (2025-2030) & (Units)
Table 67. Americas Ivosidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Ivosidenib Sales Forecast by Region (2025-2030) & (Units)
Table 69. APAC Ivosidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Ivosidenib Sales Forecast by Country (2025-2030) & (Units)
Table 71. Europe Ivosidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Ivosidenib Sales Forecast by Country (2025-2030) & (Units)
Table 73. Middle East & Africa Ivosidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Ivosidenib Sales Forecast by Type (2025-2030) & (Units)
Table 75. Global Ivosidenib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Ivosidenib Sales Forecast by Application (2025-2030) & (Units)
Table 77. Global Ivosidenib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Servier Pharmaceuticals Basic Information, Ivosidenib Manufacturing Base, Sales Area and Its Competitors
Table 79. Servier Pharmaceuticals Ivosidenib Product Portfolios and Specifications
Table 80. Servier Pharmaceuticals Ivosidenib Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Servier Pharmaceuticals Main Business
Table 82. Servier Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ivosidenib
Figure 2. Ivosidenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ivosidenib Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Ivosidenib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Ivosidenib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 60 Tablets
Figure 10. Product Picture of 30 Tablets
Figure 11. Global Ivosidenib Sales Market Share by Type in 2023
Figure 12. Global Ivosidenib Revenue Market Share by Type (2019-2024)
Figure 13. Ivosidenib Consumed in Hospital
Figure 14. Global Ivosidenib Market: Hospital (2019-2024) & (Units)
Figure 15. Ivosidenib Consumed in Pharmacy
Figure 16. Global Ivosidenib Market: Pharmacy (2019-2024) & (Units)
Figure 17. Global Ivosidenib Sales Market Share by Application (2023)
Figure 18. Global Ivosidenib Revenue Market Share by Application in 2023
Figure 19. Ivosidenib Sales Market by Company in 2023 (Units)
Figure 20. Global Ivosidenib Sales Market Share by Company in 2023
Figure 21. Ivosidenib Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Ivosidenib Revenue Market Share by Company in 2023
Figure 23. Global Ivosidenib Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Ivosidenib Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Ivosidenib Sales 2019-2024 (Units)
Figure 26. Americas Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 27. APAC Ivosidenib Sales 2019-2024 (Units)
Figure 28. APAC Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 29. Europe Ivosidenib Sales 2019-2024 (Units)
Figure 30. Europe Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Ivosidenib Sales 2019-2024 (Units)
Figure 32. Middle East & Africa Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 33. Americas Ivosidenib Sales Market Share by Country in 2023
Figure 34. Americas Ivosidenib Revenue Market Share by Country in 2023
Figure 35. Americas Ivosidenib Sales Market Share by Type (2019-2024)
Figure 36. Americas Ivosidenib Sales Market Share by Application (2019-2024)
Figure 37. United States Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Ivosidenib Sales Market Share by Region in 2023
Figure 42. APAC Ivosidenib Revenue Market Share by Regions in 2023
Figure 43. APAC Ivosidenib Sales Market Share by Type (2019-2024)
Figure 44. APAC Ivosidenib Sales Market Share by Application (2019-2024)
Figure 45. China Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Ivosidenib Sales Market Share by Country in 2023
Figure 53. Europe Ivosidenib Revenue Market Share by Country in 2023
Figure 54. Europe Ivosidenib Sales Market Share by Type (2019-2024)
Figure 55. Europe Ivosidenib Sales Market Share by Application (2019-2024)
Figure 56. Germany Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Ivosidenib Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Ivosidenib Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Ivosidenib Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Ivosidenib Sales Market Share by Application (2019-2024)
Figure 65. Egypt Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Ivosidenib in 2023
Figure 71. Manufacturing Process Analysis of Ivosidenib
Figure 72. Industry Chain Structure of Ivosidenib
Figure 73. Channels of Distribution
Figure 74. Global Ivosidenib Sales Market Forecast by Region (2025-2030)
Figure 75. Global Ivosidenib Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Ivosidenib Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Ivosidenib Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Ivosidenib Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Ivosidenib Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Ivosidenib
Figure 2. Ivosidenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ivosidenib Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Ivosidenib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Ivosidenib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 60 Tablets
Figure 10. Product Picture of 30 Tablets
Figure 11. Global Ivosidenib Sales Market Share by Type in 2023
Figure 12. Global Ivosidenib Revenue Market Share by Type (2019-2024)
Figure 13. Ivosidenib Consumed in Hospital
Figure 14. Global Ivosidenib Market: Hospital (2019-2024) & (Units)
Figure 15. Ivosidenib Consumed in Pharmacy
Figure 16. Global Ivosidenib Market: Pharmacy (2019-2024) & (Units)
Figure 17. Global Ivosidenib Sales Market Share by Application (2023)
Figure 18. Global Ivosidenib Revenue Market Share by Application in 2023
Figure 19. Ivosidenib Sales Market by Company in 2023 (Units)
Figure 20. Global Ivosidenib Sales Market Share by Company in 2023
Figure 21. Ivosidenib Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Ivosidenib Revenue Market Share by Company in 2023
Figure 23. Global Ivosidenib Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Ivosidenib Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Ivosidenib Sales 2019-2024 (Units)
Figure 26. Americas Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 27. APAC Ivosidenib Sales 2019-2024 (Units)
Figure 28. APAC Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 29. Europe Ivosidenib Sales 2019-2024 (Units)
Figure 30. Europe Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Ivosidenib Sales 2019-2024 (Units)
Figure 32. Middle East & Africa Ivosidenib Revenue 2019-2024 ($ Millions)
Figure 33. Americas Ivosidenib Sales Market Share by Country in 2023
Figure 34. Americas Ivosidenib Revenue Market Share by Country in 2023
Figure 35. Americas Ivosidenib Sales Market Share by Type (2019-2024)
Figure 36. Americas Ivosidenib Sales Market Share by Application (2019-2024)
Figure 37. United States Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Ivosidenib Sales Market Share by Region in 2023
Figure 42. APAC Ivosidenib Revenue Market Share by Regions in 2023
Figure 43. APAC Ivosidenib Sales Market Share by Type (2019-2024)
Figure 44. APAC Ivosidenib Sales Market Share by Application (2019-2024)
Figure 45. China Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Ivosidenib Sales Market Share by Country in 2023
Figure 53. Europe Ivosidenib Revenue Market Share by Country in 2023
Figure 54. Europe Ivosidenib Sales Market Share by Type (2019-2024)
Figure 55. Europe Ivosidenib Sales Market Share by Application (2019-2024)
Figure 56. Germany Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Ivosidenib Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Ivosidenib Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Ivosidenib Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Ivosidenib Sales Market Share by Application (2019-2024)
Figure 65. Egypt Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Ivosidenib Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Ivosidenib in 2023
Figure 71. Manufacturing Process Analysis of Ivosidenib
Figure 72. Industry Chain Structure of Ivosidenib
Figure 73. Channels of Distribution
Figure 74. Global Ivosidenib Sales Market Forecast by Region (2025-2030)
Figure 75. Global Ivosidenib Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Ivosidenib Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Ivosidenib Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Ivosidenib Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Ivosidenib Revenue Market Share Forecast by Application (2025-2030)
